ConductScience.org, home

Paper42565679

Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX.

Pei Le J and 9 others. Proc (Bayl Univ Med Cent), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX. Papers, record 42565679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42565679

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX.
PubMed
Journal
Proc (Bayl Univ Med Cent)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Comparative Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-24
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pei Le JJoshua
2Gupta NNavneet
3Singh SSachin
4Zafar PPalwasha
5McCraw CCameronhttps://orcid.org/0000-0003-1952-4085
6Gul RRohail
7Ahmed OOsama
8Baker Sheikh AAbu
9Patel DDhaval
10Nasrullah AAdeel

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Methylene BlueMajor topic
Shock, SepticMajor topic
HydroxocobalaminMajor topic
Humans
Retrospective Studies
Female
Male
Aged
Middle Aged
Treatment Outcome

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127852320A complex endeavour: an ethnographic study of the implementation of the Sepsis Six clinical care bundle.Implement Sci2016https://conductscience.org/library/papers/27852320PubMed
236174744
High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial).
Chest2023https://conductscience.org/library/papers/36174744PubMed
321036796The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study.Emerg Med J2011https://conductscience.org/library/papers/21036796PubMed
440466258Vasoplegia Syndrome After Cardiac Surgery: Insights Into Mechanisms and Treatment.JACC Heart Fail2025https://conductscience.org/library/papers/40466258PubMed
526903336Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).JAMA2016https://conductscience.org/library/papers/26903336PubMed
639574288Methylene Blue for Septic Shock: A Systematic Review and Meta-analysis of Randomized and Prospective Observational Studies.J Intensive Care Med2026https://conductscience.org/library/papers/39574288PubMed
736237547Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis.Front Med (Lausanne)2022https://conductscience.org/library/papers/36237547PubMed
840157894Vasoplegic Syndrome in Cardiac Surgery: A Narrative Review of Etiologic Mechanisms and Therapeutic Options.J Cardiothorac Vasc Anesth2025https://conductscience.org/library/papers/40157894PubMed
936233404Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis.J Clin Med2022https://conductscience.org/library/papers/36233404PubMed
1038698779Methylene blue in sepsis and septic shock: a systematic review and meta-analysis.Front Med (Lausanne)2024https://conductscience.org/library/papers/38698779PubMed
1131346957Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms.Can J Anaesth2019https://conductscience.org/library/papers/31346957PubMed
1236915146Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.Crit Care2023https://conductscience.org/library/papers/36915146PubMed
1338030578Treatment of refractory shock with vitamin B12 : A narrative review.Nutr Clin Pract2024https://conductscience.org/library/papers/38030578PubMed
1426903338The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).JAMA2016https://conductscience.org/library/papers/26903338PubMed
1531187494High-Dose Vitamin B12 in Vasodilatory Shock: A Narrative Review.Nutr Clin Pract2019https://conductscience.org/library/papers/31187494PubMed
1639438181Hydroxocobalamin Versus Methylene Blue for Treatment of Vasoplegic Shock Following Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.J Cardiothorac Vasc Anesth2024https://conductscience.org/library/papers/39438181PubMed
1732019600Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.Crit Care2020https://conductscience.org/library/papers/32019600PubMed
1836705345Effect of methylene blue on hemodynamic response in the early phase of septic shock: A case series.Medicine (Baltimore)2023https://conductscience.org/library/papers/36705345PubMed
1922534716Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.Med Sci Monit2012https://conductscience.org/library/papers/22534716PubMed
2037147207Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.J Cardiothorac Vasc Anesth2023https://conductscience.org/library/papers/37147207PubMed

See all 33 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42565679

GET https://conductscience.org/api/papers/v1/42565679/references?page=2